Kutaini Dirar, Davila Carol
J Med Life. 2010 Jul-Sep;3(3):348-50.
The aim of this article is to present the development of the pharmaceutical industry in Syria using national and international public data sources. At the end of the 80ies, the pharmaceutical industry in Syria was very poor, covering 6% of the national needs. In less than 20 years, with the government support in terms of legal frame and strategic political engagement, the Syrian pharmaceutical industry finally covered almost 90% of the national needs, in terms of drugs, and exported drugs in around 52 Arabian countries. Beyond covering the local market, the main added values of this huge development consisted in exporting drugs in amount of 150 million dollars per year and providing jobs for 17000 Syrian people, out of which around 85% are women. Strong and weak points of the pharmaceutical sector are taken into consideration in the article and further interventions to support a sustainable development are proposed by the author.
本文旨在利用国家和国际公共数据源介绍叙利亚制药行业的发展情况。在80年代末，叙利亚的制药行业非常落后，仅能满足6%的国内需求。在不到20年的时间里，在政府的法律框架支持和战略政治参与下，叙利亚制药行业最终在药品方面几乎满足了90%的国内需求，并向约52个阿拉伯国家出口药品。除了满足当地市场需求外，这一巨大发展的主要附加值在于每年出口价值1.5亿美元的药品，并为17000名叙利亚人提供了就业机会，其中约85%为女性。文章考虑了制药部门的优缺点，并由作者提出了进一步支持可持续发展的干预措施。
